menu
    • menu
    [{"orgOrder":0,"company":"University of Birmingham","sponsor":"Cancer Research","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"UNITED KINGDOM","productType":"Cytotoxic Drug","year":"2020","type":"Inapplicable","leadProduct":"AZD4547","moa":"FGFR1","graph1":"Oncology","graph2":"Phase II","graph3":"University of Birmingham","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"University of Birmingham \/ Cancer Research","highestDevelopmentStatusID":"8","companyTruncated":"University of Birmingham \/ Cancer Research"}]

    Find Clinical Drug Pipeline Developments & Deals for AZD4547

    Menu

    AZD4547

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University of Birmingham

                            Country arrow
                            The Generic Rx Session
                            Not Confirmed

                            University of Birmingham

                            Country arrow
                            The Generic Rx Session
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : AZD4547

                            Therapeutic Area : Oncology

                            Study Phase : Phase II

                            Sponsor : Cancer Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Flagship Cancer Research UK Precision Medicine Trial Highlights the Need for a New Approach in Treating Genomi...

                            Details : Using an innovative trial design that incorporates multiple treatment arms, NLMT allows for a more flexible and informed approach than traditional clinical trials.

                            Product Name : AZD4547

                            Product Type : Cytotoxic Drug

                            Upfront Cash : Inapplicable

                            July 16, 2020

                            Lead Product(s) : AZD4547

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase II

                            Sponsor : Cancer Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth